Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 07-Apr-2021
No. of pages: 123
Inquire Before Buying

Global Healthcare-associated Infectious Disease Diagnostics Scope and Market Size

Healthcare-associated Infectious Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare-associated Infectious Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Urinary Tract Infections

- Surgical Site Infections

- Hospital-acquired Pneumonia

- BloodStream Infections

- Gastrointestinal Infections

Segment by Application

- Hospitals

- Clinics

- ASCs

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Abbott

- Accelerate Diagnostics

- BD

- bioMrieux

- Bio-Rad

- DiaSorin Molecular

- F. Hoffmann-La Roche

- Luminex

- Meridian Bioscience

- OpGen

- QIAGEN

- Quidel

- Thermo Fisher Scientific

- Trinity Biotech

- Danaher

Global Healthcare-associated Infectious Disease Diagnostics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Urinary Tract Infections
1.2.3 Surgical Site Infections
1.2.4 Hospital-acquired Pneumonia
1.2.5 BloodStream Infections
1.2.6 Gastrointestinal Infections
1.3 Market by Application
1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 ASCs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2016-2027)
2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Regions
2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Healthcare-associated Infectious Disease Diagnostics Industry Dynamic
2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Trends
2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.2.5 Accelerate Diagnostics Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.3.5 BD Recent Development
11.4 bioMrieux
11.4.1 bioMrieux Company Details
11.4.2 bioMrieux Business Overview
11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.4.5 bioMrieux Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Details
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.5.5 Bio-Rad Recent Development
11.6 DiaSorin Molecular
11.6.1 DiaSorin Molecular Company Details
11.6.2 DiaSorin Molecular Business Overview
11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.6.5 DiaSorin Molecular Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 F. Hoffmann-La Roche Business Overview
11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Luminex
11.8.1 Luminex Company Details
11.8.2 Luminex Business Overview
11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.8.5 Luminex Recent Development
11.9 Meridian Bioscience
11.9.1 Meridian Bioscience Company Details
11.9.2 Meridian Bioscience Business Overview
11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.9.5 Meridian Bioscience Recent Development
11.10 OpGen
11.10.1 OpGen Company Details
11.10.2 OpGen Business Overview
11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.10.5 OpGen Recent Development
11.11 QIAGEN
11.11.1 QIAGEN Company Details
11.11.2 QIAGEN Business Overview
11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.11.5 QIAGEN Recent Development
11.12 Quidel
11.12.1 Quidel Company Details
11.12.2 Quidel Business Overview
11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.12.5 Quidel Recent Development
11.13 Thermo Fisher Scientific
11.13.1 Thermo Fisher Scientific Company Details
11.13.2 Thermo Fisher Scientific Business Overview
11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.13.5 Thermo Fisher Scientific Recent Development
11.14 Trinity Biotech
11.14.1 Trinity Biotech Company Details
11.14.2 Trinity Biotech Business Overview
11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.14.5 Trinity Biotech Recent Development
11.15 Danaher
11.15.1 Danaher Company Details
11.15.2 Danaher Business Overview
11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021)
11.15.5 Danaher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Urinary Tract Infections
Table 3. Key Players of Surgical Site Infections
Table 4. Key Players of Hospital-acquired Pneumonia
Table 5. Key Players of BloodStream Infections
Table 6. Key Players of Gastrointestinal Infections
Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2016-2021)
Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2022-2027)
Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2020)
Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Healthcare-associated Infectious Disease Diagnostics Product
Table 67. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Accelerate Diagnostics Company Details
Table 70. Accelerate Diagnostics Business Overview
Table 71. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
Table 72. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 73. Accelerate Diagnostics Recent Development
Table 74. BD Company Details
Table 75. BD Business Overview
Table 76. BD Healthcare-associated Infectious Disease Diagnostics Product
Table 77. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 78. BD Recent Development
Table 79. bioMrieux Company Details
Table 80. bioMrieux Business Overview
Table 81. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
Table 82. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 83. bioMrieux Recent Development
Table 84. Bio-Rad Company Details
Table 85. Bio-Rad Business Overview
Table 86. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
Table 87. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Bio-Rad Recent Development
Table 89. DiaSorin Molecular Company Details
Table 90. DiaSorin Molecular Business Overview
Table 91. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
Table 92. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 93. DiaSorin Molecular Recent Development
Table 94. F. Hoffmann-La Roche Company Details
Table 95. F. Hoffmann-La Roche Business Overview
Table 96. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
Table 97. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 98. F. Hoffmann-La Roche Recent Development
Table 99. Luminex Company Details
Table 100. Luminex Business Overview
Table 101. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Luminex Recent Development
Table 103. Meridian Bioscience Company Details
Table 104. Meridian Bioscience Business Overview
Table 105. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
Table 106. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 107. Meridian Bioscience Recent Development
Table 108. OpGen Company Details
Table 109. OpGen Business Overview
Table 110. OpGen Healthcare-associated Infectious Disease Diagnostics Product
Table 111. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 112. OpGen Recent Development
Table 113. QIAGEN Company Details
Table 114. QIAGEN Business Overview
Table 115. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
Table 116. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 117. QIAGEN Recent Development
Table 118. Quidel Company Details
Table 119. Quidel Business Overview
Table 120. Quidel Healthcare-associated Infectious Disease Diagnostics Product
Table 121. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 122. Quidel Recent Development
Table 123. Thermo Fisher Scientific Company Details
Table 124. Thermo Fisher Scientific Business Overview
Table 125. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
Table 126. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 127. Thermo Fisher Scientific Recent Development
Table 128. Trinity Biotech Company Details
Table 129. Trinity Biotech Business Overview
Table 130. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
Table 131. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 132. Trinity Biotech Recent Development
Table 133. Danaher Company Details
Table 134. Danaher Business Overview
Table 135. Danaher Healthcare-associated Infectious Disease Diagnostics Product
Table 136. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 137. Danaher Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Urinary Tract Infections Features
Figure 3. Surgical Site Infections Features
Figure 4. Hospital-acquired Pneumonia Features
Figure 5. BloodStream Infections Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. ASCs Case Studies
Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions: 2020 VS 2027
Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Regions (2022-2027)
Figure 16. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2020
Figure 17. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2020
Figure 19. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2016-2021)
Figure 20. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2022-2027)
Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 23. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 24. North America Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 25. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2016-2027)
Figure 29. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2016-2027)
Figure 30. Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Country (2016-2027)
Figure 31. Germany Healthcare-associated Infectious Disease Diagnostics Market Size Y
  • Medical Device Outsourced Manufacturing Market by Device Type (IVD (Equipment, Consumable), Diabetes, Respiratory, Cardiovascular, Personal Care, Endoscopy, Dental, Ophthalmology, Devices) Class of Device, Services, Procedure - APAC forecast to 2026
    Published: 21-Apr-2021        Price: US 5650 Onwards        Pages: 306
    The medical device outsourced manufacturing market is expected to grow at a CAGR of 13.9% in the forecast period. The Asia Pacific medical device outsourced manufacturing market is projected to reach USD 56.2 billion by 2026 from USD 29.3 billion in 2021 and is expected to grow at a CAGR of 13.9% during the forecast period. The Asia pacific medical device outsourced manufacturing market is mainly driven by the overall growth of the medical devices market, mainly due t......
  • Global Medical Guidewires Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 124
    The global Medical Guidewires market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Guidewires market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Straight Guidewires - J shaped Guidewir......
  • Global Medical Gynecological Devices Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 132
    The global Medical Gynecological Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Gynecological Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Vaginal Speculum ......
  • Global Medical Silicone Wires and Cables Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 125
    The global Medical Silicone Wires and Cables market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medical Silicone Wires and Cables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Medical Tubing......
  • Global Capillary Electrophoresis Systems Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 136
    The global Capillary Electrophoresis Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Capillary Electrophoresis Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Automatic Capill......
  • Global Point of Care CT Imaging Systems Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 121
    The global Point of Care CT Imaging Systems market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care CT Imaging Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Compact CT Scanner......
  • Global Robotic Aseptic Syringe Filler Cappers Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 116
    The global Robotic Aseptic Syringe Filler Cappers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Robotic Aseptic Syringe Filler Cappers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Primar......
  • Global Digital X-Ray Devices Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 118
    The global Digital X-Ray Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Digital X-Ray Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Retrofit X-ray Systems - New Digi......
  • Global Veterinary Chemistry Analyzers Sales Market Report 2021
    Published: 21-Apr-2021        Price: US 4000 Onwards        Pages: 128
    The global Veterinary Chemistry Analyzers market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Chemistry Analyzers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Chemistry Analyzers......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs